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Sex differenceAquaporin 4 (AQP4), the most abundant water channel protein in the brain, is involved in brain edema
induced by ischemic insults. To evaluate whether the neuroprotective effects of estrogen are associated with
AQP4 expression and edema formation, changes in AQP levels and ischemic edema were examined in the
brains of male and female mice subjected to transient middle cerebral artery occlusion. Infarct volume and
edema formation were markedly less in females than in males. AQP4 expression in the ischemic cortex of
females was relatively well preserved, whereas it was signiﬁcantly decreased in males. These effects
disappeared in ovariectomized females but were reversed by estrogen replacement. Furthermore, AQP4
expression was decreased with increased brain edema in females treated with ICI182,780, an estrogen
receptor antagonist. These ﬁndings suggest that the estrogen effect on the reduction of ischemic brain edema
is associated with the preserved level of AQP4 that is partly mediated by estrogen receptors.ogy, School of Medicine, Ewha
, Seoul 158-710, Republic of
ll rights reserved.© 2011 Elsevier B.V. All rights reserved.1. Introduction
Development of brain edema is the major cause of death in
patients with sizable ischemic stroke because it produces elevated
intracranial pressure that leads to secondary brain damage, such as
reduction in perfusion pressure and compression of vital areas of the
brain [1,2]. Despite its clinical importance, medical management has
been ineffective at controlling brain edema in patients with stroke [1],
indicating that a better understanding of the pathophysiology of
edema formation in the ischemic brain is required for the manage-
ment of edema.
Aquaporin 4 (AQP4) is a water channel protein and is the most
abundant aquaporin in the brain. It is located in astroglial endfeet
around the microvessels associated with the blood–brain barrier
(BBB), glia limitans, and ependyma, suggesting that AQP4 has an
important role in the movement of water into and out of the brain
[3,4]. Animal studies of brain injuries indicate that AQP4 is implicated
in the pathogenesis of cerebral edema, as shown by an association of
altered expression with the degree of edema formation in injured
brain. Direct studies using AQP4 null mice have shown different roles
for AQP4 according to the type of edema, that is, cytotoxic (ﬂuidaccumulation within cells) and vasogenic edema (extracellular
swelling caused by increased permeability of the BBB) [5]. Brain
swelling and mortality of mice with cytotoxic edema were reduced,
whereas vasogenic edema was increased in AQP4 null mice compared
to wild-type mice [6,7]. In an ischemic stroke model, AQP4 null and
alpha syntrophin null (functionally disrupted AQP4) mice showed a
reduction in hemispheric swelling [6,8], and the authors suggested
that AQP4 contributes to edema formation. However, other studies
showed the increased expression of AQP4 in the borderzone or
periinfarct area, but not in the central part of ischemic brain [9,10],
suggestingpositive roles of AQP4 in the salvageable brain. Therefore, the
functional signiﬁcance of up- or down-regulated AQP4 in ischemia-
induced edema formation remains unclear.
It has been well documented that the female brain is resistant to
ischemic injury during the reproductive period compared to that of
males and that estrogen plays an important role in this neuroprotec-
tion [11]. Multiple studies have shown a smaller infarct volume in
females, but few studies have evaluated the effects of sex and sex
hormones on ischemic edema, and furthermore, the ﬁndings are
inconsistent [12–15]. Recent studies demonstrated no sex difference
in ischemic brain edema [12,13], whereas others reported that
estrogen reduces brain edema induced by focal ischemic stroke
[14,15]. In traumatic brain injury (TBI) models that induce vasogenic
edema, the lesion volume is reduced in females compared to males,
and estrogen and progesterone administration reduces brain edema
in males and ovariectomized rodents [16–18]. These results and the
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the brain [18–20] led us to hypothesize that the vasogenic component
of ischemic edema can be inﬂuenced by sex hormones through
regulation of AQP4 expression.
Using ovariectomized mice given estrogen replacement, we previ-
ously demonstrated sex differences in the infarct volume following
experimental ischemic stroke, and conﬁrmed that estrogen was
responsible for the neuroprotective effects in females [21]. Our current
study was conducted to deﬁne sex differences in brain edema that
is induced by ischemic stroke, and the effects of estrogen on AQP4
expression and edema formation. In addition, the role of estrogen
receptors (ERs) in AQP4 expression was evaluated in the ischemic
brain by treating female mice with an ER antagonist, ICI182,780.
2. Materials and methods
2.1. Animals
Experiments were performed in male and female C57BL/6 mice
(age 10–11 weeks, Orient Bio Inc., Seongnam, Republic of Korea). All
procedures were approved by the Institutional Animal Care and Use
Committee at the Medical School of Ewha Womans University andFig. 1. Reduced infarct volume in female mice. (A) Cerebral blood ﬂow changes during
ischemia and reperfusion inmales (n=9) and females (n=10). (B) Representative brain
sections of cresyl violet staining 3 days after MCAO in male and female mice. (C) Infarct
volumes in total hemisphere, cortex and striatum in male (n=9) and female (n=10)
mice 3 days afterMCAO. *pb0.05 compared to the corresponding infarct volume ofmales
(Student's t-test). The data are expressed as the mean±SEM.conformed to international guidelines on the ethical use of animals.
Before the experiment, mice were acclimatized for 1 week in an
animal room under a 12-h light/dark cycle at 22±2 °C. The number of
animals used for the study was minimized to reduce animal suffering.
2.2. Transient middle cerebral artery occlusion (MCAO)
Procedures for transient MCAO were described previously [22].
Brieﬂy, mice were anesthetized with isoﬂurane, and a ﬁber optic
probe was attached to the right parietal bone (2 mm posterior and
5 mm lateral to bregma) and connected to a laser-Doppler ﬂowmeter
(Periﬂux System 5010, Perimed, Sweden). Cerebral blood ﬂow (CBF)Fig. 2. Reduced ischemic brain edema in female compared to male mice. (A) Time course
of hemispheric brain edema afterMCAO inmales (n=4–5). *pb0.05 compared to control
and 6 h after reperfusion. #pb0.05 compared to 24 h after reperfusion (ANOVAwith post-
hoc Fisher's PLSD test). (B) Evans blue extravasation at 6 and 24 h after reperfusion
(control; n=3, 6 and 24 h; n=5). *pb0.05 compared to control and 6 h after reperfusion
(ANOVAwith post-hoc Fisher's PLSD test). (C) Brain edema inmale and femalemice at 24
and 72 h after MCAO (n=4–5). Male data are the same as in (A), and are reproduced
here for comparison. *pb0.05compared tomales (Student's t-test). Thedata are expressed
as the mean±SEM.
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with a computer-based data acquisition system (Perisoft, Perimed,
Sweden). A 6–0 silicon-coated black monoﬁlament surgical suture
(Doccol Cooperation, Redlands, CA, USA) was inserted into the
exposed right external carotid artery, advanced into the internal
carotid artery, and wedged into the circle of Willis to obstruct the
origin of the MCA. The ﬁlament was left in place for 30 min and then
withdrawn to re-establish CBF. Only animals that exhibited a
reduction in CBF N85% during MCA occlusion and in which CBF
recovered by N80% after 10 min of reperfusion were included in the
study. Rectal temperature was maintained at 37.0±0.5 °C with a
thermostatically controlled heating pad during surgery and recovery
until the animal regained consciousness.
2.3. Ovariectomy, drug administration, and measurement of estrogen
activity
Two weeks before MCAO, female mice underwent aseptic bilateral
surgical ovariectomy via a dorsal incision under isoﬂurane anesthesia.
Ovariectomized (OVX) female mice were divided randomly into
vehicle and estrogen replacement groups, and vehicle (0.1 ml of
sesame oil) or estrogen benzoate (1 μg in 0.1 ml of sesame oil; Sigma-
Aldrich, St. Louis, MO, USA) was administered subcutaneously for
6 days starting 3 days before MCAO. The ER antagonist ICI182,780
(100 μg in 0.1 ml of sesame oil, subcutaneously; Tocris Bioscience,
Bristol, UK) was given to gondally intact female mice for 10 days
starting 7 days before MCAO. Naïve control mice for vehicle, estrogen
benzoate, or ICI182,780 were treated with each drug for 10 days
without MCAO. The doses of estrogen benzoate and ICI182,780 were
adopted from previous studies that showed their effects in the brains
of female mice [21,23]. To measure estrogen activity, blood was
collected at the time of euthanasia, and plasma estradiol levels were
measured with an ELISA assay kit (Cayman Chemical, Ann Arbor, MI,
USA) according to the manufacturer's instructions. Uterine weight was
also measured at the end of experiment to conﬁrm estrogen activity.
2.4. Measurement of infarct volume and brain edema
Infarct volume was measured according to procedures described
previously [24]. Mice were euthanized 72 h after MCAO, and brains
were removed, frozen, and sectioned (30 μm thick) with a cryostat.
Brain sections were collected serially at 600-μm intervals, and stained
with cresyl violet. Infarct volume was determined with an image
analyzer (Axiovision LE 4.1, Carl Zeiss, Jena, Germany). Values were
reported after correcting for post-ischemic swelling. To measure brain
edema, the whole brain was quickly removed and dissected into right
and left hemispheres, which were weighed (wet wt). Dry weight
(dry wt) of each hemisphere was determined after drying the tissue
for 3 days at 100 °C in an oven. The hemispheric water content was
determined as % water content=(1− dry wt/wet wt)×100 [24], and
then edema index was calculated by putting water content in
ipsilateral over that in the contralateral hemisphere [13].
2.5. Measurement of Evans blue extravasation
Ten minutes after reperfusion, 5 ml/kg of 2% Evans blue (Sigma-
Aldrich) in normal saline was injected into the tail vein. Six or 24 hFig. 3. Sex difference in AQP4 expression in the ischemic cortex. (A) Time course of AQP4mR
in males and females (n=4 per time point for males and females except control; n=3). Valu
compared to male control, #pb0.05 compared to the corresponding time point in males (S
blotting and their quantitative levels normalized to actin in the ischemic cortex after MCAO i
*pb0.05 compared to each control, #pb0.05 compared to the corresponding time point in
expression of Kir4.1 proteins with Western blotting and their quantitative levels normalized
expressed as the mean±SEM.after reperfusion, mice were anesthetized with sodium pentobarbi-
tal (120 mg/kg, i.p.) and perfused transcardially with normal saline.
Brains were removed, and each hemisphere was homogenized in
1 ml 50% trichloroacetic acid and centrifuged at 15,700×g for 20 min
at 4 °C. The supernatants were diluted 4-fold with ethanol, and
analyzed at 650 nm by spectrophotometry [25]. Evans blue extrav-
asation was quantiﬁed as μg per hemisphere in comparison with a
standard curve, and Evans blue index was calculated by putting
Evans blue concentration in ipsilateral over that in the contralateral
hemisphere [13].
2.6. RNA isolation and real-time PCR analysis
RNA was isolated from the ipsilateral hemisphere cortex and
subjected to quantitative real-time PCR. Total RNA was prepared
with Trizol reagent (Invitrogen Life Technologies, Carlsbad, CA,
USA). Tissues were homogenized by sonicating in 0.5 ml Trizol, and
RNA was puriﬁed using chloroform/isopropanol precipitation and
dissolved in diethylpyrocarbonate-treated water (iNtRON Biotech-
nology, Seongnam, Republic of Korea). First strand synthesis was
performed with 1 μg of total RNA from each sample and 1 μl (6.7 μM)
of oligo (dT)15, with a Power cDNA Synthesis kit (iNtRON
Biotechnology). A 2-μl aliquot of diluted cDNA (1:10) was ampliﬁed
with SYBR® Green PCR Master Mix (Applied Biosystems, Foster
City, CA, USA) in a ﬁnal volume of 20 μl. PCR was performed in an
ABI Prism 7000 sequence detector (Applied Biosystems). PCR cycles
consisted of initial denaturation at 95 °C for 5 min, followed by
40 cycles of 95 °C for 30 s, 56 °C for 30 s, and 72 °C for 45 s. The
primers for cyclophilin (forward: 5′-TAGAGCTGTCCACAGTCGGA-3′;
reverse: 5′-TTCATCTGCACTGCCAAGAC-3′) and AQP4 (forward: 5′-
GGAAGGCTAGGTTGGTGACTTC-3′; reverse: 5′-TGGTGACTCC-
CAATCCTCCAAC-3′) were purchased from Bioneer (Daejoen, Repub-
lic of Korea). Cycling threshold (Ct) values of AQP4 were normalized
to the Ct values of cyclophilin, and the relative expression level
was calculated with the 2−ΔΔCt method [26]. All samples were run in
triplicate, and naïve animals (n=3) served as controls.
2.7. Western blot analysis
Cortical tissues from the ipsilateral hemisphere of each animal
were subjected to simultaneous western blotting. Tissues were
lysed in 10 ml sodium dodecyl sulfate (SDS) buffer (62 mM Tris–
HCl, 1 mM ethylenediamine tetraacetic acid, 2% SDS, pH 6.8–7.0)
containing a protease inhibitor cocktail (Complete Mini, Boehringer
Mannheim, Germany), incubated for 20 min on ice, and centrifuged
at 15,700×g for 10 min at 4 °C. Protein concentration of the
supernatant was determined (Bio-Rad Laboratories, Hercules, CA,
USA), and 80 μg of protein was loaded for SDS-polyacrylamide gel
electrophoresis. Proteins were transferred to Immobilon-P transfer
(Millipore Corporate, Billerica, MA, USA) with an electroblotting
apparatus. Membranes were blocked in Tris-buffered saline (TBS)
containing 0.1% Tween-20 and 5% dry milk for 1 h, incubated
overnight with antibodies against AQP4 (1:1000; Abcam, Cam-
bridge, UK), GFAP (1:1000; Sigma, USA), or Kir4.1 (the inward
rectifying K+ channel of astrocyte, 1:500; Santa Cruz Biotechnology,
Santa Cruz, CA, USA), and washed three times (20 min each) with
TBS containing 0.1% Tween-20. The membranes were thenNA expression by PCR and quantitative real-time PCR in the ischemic cortex after MCAO
es are expressed as the ratio versus male controls (given a nominal value of 1). *pb0.05
tudent's t-test). (B) Time course expression of AQP4 and GFAP proteins with Western
n males and females (n=4 per time point for males and females except control; n=3).
males (Student's t-test). The data are expressed as the mean±SEM. (C) Time course
to actin in the ischemic cortex after MCAO in males and females (n=3). The data are
Fig. 4. Vessel-shaped AQP4 expression is preserved in the ischemic cortex of females. Immunoﬂuorescence staining for GFAP (green, A, E, and I), AQP4 (red, B, F, and J), the merged
images (yellow, C, G, and K), and enlarged images of white boxed areas (D, H, and L) in male control (A–D) and ischemic cortices of male (E–H) and female (I–L) 24 h after MCAO. An
area taken in the ischemic cortex (red box) for image analysis is depicted in (E). Arrowheads indicate colocalization of GFAP and AQP4. Representative images were obtained from
one set of experiments, and three experiments were done independently. Scale bar=50 μm in A–C, E–G, and I–K; 10 μm in D, H, and L.
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bodies for 1 h each and washed three times (20 min each) with TBS
containing 0.1% Tween-20. Protein bands were visualized with the
Western Blotting Luminal Reagent (Santa Cruz Biotechnology). Each
membrane was re-blotted with anti-actin (1:1000; Santa Cruz
Biotechnology) after stripping with an antibody stripping solution
(Chemicon International, Temecula, CA, USA) according to the
manufacturer's instructions. For quantiﬁcation, densities of AQP4,
GFAP, and Kir4.1 bands were normalized to the density of actin
bands measured with Image J 1.37v program (NIH, USA).2.8. Immunoﬂuorescence staining
Animals were anesthetized with sodium pentobarbital (120 mg/
kg, i.p.) and perfused transcardially with saline followed by 4% cold
formaldehyde in 0.1 M sodium phosphate buffer (pH 7.2). The brains
were removed, incubated overnight in ﬁxative, and stored in a 30%
sucrose solution. Serial coronal brain sections (20-μm thick, 600-μm
interval) were collected in a cryostat in regions between +1.4 and
−1.0 mm from bregma. Brain sections were incubated in TBS
containing 0.1% Triton X-100, 5% normal serum, and 1% bovine
serum albumin for 1 h and then incubated with AQP4 antibody
(1:500; Santa Cruz Biotechnology) and GFAP antibody (1:500;
Sigma). On the following day, the secondary antibodies Alexa
ﬂuor®555 (1:1000; Molecular Probes, Eugene, OR, USA) and FITC
(1:1000; Vector Laboratories, Inc., Burlingame, CA, USA) were
applied to sections for 1 h. Sections were washed with TBS between
all steps. The sections were mounted with Vectashield mounting
medium (Vector Laboratories, Inc.). Fluorescence images of lateral
cortex were obtained at a 4-μm thickness through the z axis of the
section covering a total of 20 μm in depth with a confocal microscope
(LSM5 PASCAL; Carl Zeiss) equipped with a ﬁlter set with excitation
at 488 and 543 nm.2.9. Statistical analysis
The data are expressed as the mean±SEM. Comparisons
between two groups were analyzed with an unpaired Student's t-
test. Multiple comparisons were evaluated with one-way analysis of
variance (ANOVA), followed by a post-hoc Fisher's protected least
signiﬁcant difference (PLSD) test with Statview (Statview version 5,
SAS Institute Inc., Cary, NC, USA). Differences were considered
signiﬁcant at pb0.05.
3. Results
3.1. Reduced ischemic brain edema and infarct volume in female mice
First, we examined the infarct volumes between the sexes to con-
ﬁrm the sex difference in our stroke model. The total infarct volume
was markedly reduced in females compared to males (pb0.001), and
the reduction was only signiﬁcant in the cortex (pb0.001) and not in
the striatum, which is the ischemic core (Fig. 1B and C). CBF changes
during MCAO and reperfusion were not different between males and
females (Fig. 1A). These ﬁndings are consistent with previous results
showing that the female brain is resistant to focal ischemic insult and
that the spared brain was the cortex, the area of ischemic penumbra
[11,21,27]. Next, the time course of brain edema was examined in
male brains to determine the time for comparison between sexes.
Ischemic brain edema was not signiﬁcant at 6 h, but was signiﬁcantly
increased at 24 h (pb0.001) and further enhanced at 72 h after
reperfusion compared to naïve control mice (Fig. 2A). To determine
whether brain edema formationwas related to BBB breakdown, Evans
blue extravasation was measured at 6 and 24 h after reperfusion.
Evans blue was detected at 6 h (p=0.364), but it was signiﬁcantly
increased at 24 h (p=0.022) compared to control (Fig. 2B). These
ﬁndings suggest that vasogenic edema caused by BBB breakdown
contributes to edema formation at 24 h after reperfusion. Based on
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after reperfusion and observed less edema formation in female brains
compared to male up to 72 h (Fig. 2C). These results showed that notFig. 5. Estrogen maintains AQP4 expression in the ischemic cortex and reduces ischemic edem
cortices ofOVXmice andOVXmice given estrogen replacement (OVX+E)24 h afterMCAO(n=
of 1). #pb0.05 between OVXmice and OVX+Emice 24 h after MCAO (Student's t-test). (B) Rep
ischemic cortices of OVX and OVX+Emice 24 h after MCAO (n=3 per group). *pb0.05 compa
(Student's t-test). (C) Infarct volumes in total hemisphere, cortex and striatum fromOVX (n=9
infarct volume of OVX mice (Student's t-test). (D) Brain edema in OVX (n=4) and OVX+E (n
(1 μg/mouse, s.c.) was given to OVX mice for 6 days starting 3 days before MCAO. The data areonly infarct volume but also edema formation was reduced in the brain
of females, supporting the view that the extent of edema formation
is associated with the degree of ischemic brain damage [25,28].a. (A) Representative blots and quantitative levels of AQP4 mRNA in control and ischemic
3 per group). Values are expressed as the ratio versusOVX controls (givenanominal value
resentative blots and quantitative levels of AQP4, Kir4.1, and GFAP proteins in control and
red to OVX control mice, #pb0.05 between OVXmice and OVX+Emice 24 h after MCAO
) and OVX+E (n=10)mice 3 days after MCAO. #pb0.05 compared to the corresponding
=4) mice 24 h after MCAO. *pb0.05 compared to OVX mice (Student's t-test). Estrogen
expressed as the mean±SEM.
Table 1
Serum estradiol levels and uterine weights in females according to treatments.
Treatment Female Female+ICI182,780 OVX OVX+E
(n=5) (n=5) (n=5) (n=5)
Serum estradiol
(pg/ml)
3.98±0.24 3.32±0.57 1.88±0.43* 4.30±1.0
Uterine weight
(mg)
90.4±25.17 27.8±0.92* 13±1.27* 100.52±6.04
OVX, ovariectomy; OVX+E, OVX with estrogen replacement.
*pb0.05 compared to gonadally intact female and OVX+E.
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sexes
To evaluate whether the difference in brain edema between sexes
was related to the expression of AQP4, mRNA and protein levels
of AQP4 were examined. Because the infarct volume of the cortex
was different between males and females (Fig. 1C), the remaining
experiments were done with ipsilateral cortical tissues. The basal
levels of AQP4 mRNA in controls were not statistically different
between sexes (p=0.43), although a slight increase was noted in
females. After ischemic reperfusion, AQP4 mRNA expression de-
creased in males at 24 and 72 h, whereas levels were maintained in
females up to 72 h (Fig. 3A). Therefore, sex differences in AQP4 mRNA
expression were observed at 24 and 72 h (p=0.005 and p=0.012,
respectively). AQP4 protein levels were decreased in both males and
females from 24 to 72 h, but the reduction was signiﬁcantly smaller in
females than in males (p=0.001 at 24 h and pb0.001 at 72 h, Fig. 3B).
To determine whether the reduction in AQP4 expression was due
to loss of cells following ischemic insult, the levels of the astrocyte
marker GFAP were examined. GFAP protein levels in the ischemic
cortex of males were not statistically different compared to controls,
although there was a trend towards decreased expression with time
after reperfusion (Fig. 3B). In female brains, a reduction in GFAP was
observed only at 72 h compared to naïve controls (p=0.025).
However, there was no sex difference in GFAP levels, indicating that
AQP4 reduction in males was not caused by loss of astrocytes. We also
examined protein levels of inwardly rectifying K+ channel subunit 4.1
(Kir4.1) that colocalizes with AQP4 in astrocytes [29] and may be
associated with AQP4-mediated water ﬂux [30]. As GFAP expressions,
its level was not different between sexes at any reperfusion periods
(Fig. 3C), suggesting that AQP4 expressions of astrocytes were
speciﬁcally decreased in male brains by ischemic injury. In addition,
immunoﬂuorescence staining of AQP4 in the ischemic cortex 24 h
after reperfusion supported the result of AQP4 protein level that its
expression in female brains was maintained (Fig. 4J). In male brains,
the intensity of AQP4 was weak, and its outline around vessels was
less clearly deﬁned (Fig. 4F). Vessel-shaped AQP4-positive cells were
colocalized with endfeet of astrocytes stained with GFAP in females
(yellow, Fig. 4K and L), but this colocalization was not clearly
observed in males (Fig. 4G and H).
Considering the correlation between the extent of brain edema
and the levels of AQP4 at 24 and 72 h after reperfusion (Fig. 2C),
conserved AQP4 expression at both the mRNA and protein levels may
contribute to reduced edema formation in female ischemic cortex.
3.3. Effect of estrogen on AQP4 expression and ischemic brain edema
To evaluate whether AQP4 expression was affected by the female
sex hormone estrogen, estradiol was administrated to OVX mice,
and AQP4 levels were examined 24 h after reperfusion, the time
at which sex differences in AQP4 expression were apparent. OVX
mice showed decreased levels of AQP4 compared to naïve controls,
whereas estrogen replacement reversed the reduction of both mRNA
(p=0.033) and protein (p=0.036) levels 24 h after reperfusion
(Fig. 5A and B). To determine whether Kir4.1 expression was also
affected by estrogen, Kir4.1 protein levels were examined. Kir4.1
levels were not changed in the ischemic brain, and levels were not
different between OVX mice with and without estrogen replacement
(Fig. 5B). GFAP protein was also not affected by estrogen. The ﬁndings
indicate that AQP4 expression in astrocytes is speciﬁcally affected
by estrogen in the ischemic female brain. Next, estrogen effects on
infarct volume and edema formation were examined. We conﬁrmed
the protective effect of estrogen by showing that estrogen replace-
ment decreased the total and cortical infarct volumes (pb0.001
compared to OVX), which were increased by OVX (Fig. 5C). In
addition, increased ischemic edema in OVX mice was reduced byestrogen 24 h after reperfusion (p=0.01, Fig. 5D). Serum estradiol
levels and uterine weights were decreased by OVX and were reversed
by estrogen replacement to the level of gonadally intact females
(Table 1). These results suggest that preserved AQP4 expression
and reduced edema formation in the female ischemic brain is
regulated by estrogen.
3.4. AQP4 expression in the ischemic cortex is mediated by ERs
Next, to examine whether estrogen maintained AQP4 levels in
ischemic brain via ERs, AQP4 expression was examined in females
treated with ICI182,780, an ER antagonist. Compared to gonadally
intact females, ICI182,780 reduced the levels of AQP4 mRNA and
protein (p=0.038 and p=0.039, respectively, Fig. 6A and B), whereas
GFAP and Kir4.1 were not affected by ICI182,780 (Fig. 6B). These
data indicate that AQP4 expression is maintained by ERs. To con-
ﬁrm the role of ERs in neuroprotection afforded by estrogen, the
infarct volume was measured in females treated with ICI182,780.
The total and cortical infarct volumes were signiﬁcantly increased
by ICI182,780 (pb0.001 compared to untreated females, Fig. 6C).
ICI182,780 did not affect serum estradiol levels but decreased uterine
weight compared to untreated females (Table 1). These ﬁndings are
in agreement with a previous study showing receptor-mediated
estrogen effects in the ischemic brain [23]. To determine the effects
of ERs on ischemic edema formation, brain edema in females treated
with ICI182,780 was compared to untreated females. Ischemic
edema was signiﬁcantly increased by ICI182,780 (p=0.029 between
treated and non-treated females, Fig. 6D). These results suggest that
ER-mediated regulation of AQP4 levels contributes to reduction of
ischemic edema formation.
4. Discussion
Our current study showed that ischemic brain edema was reduced
in females and that the extent of edema was correlated with pre-
served expression of AQP4. Furthermore, we provided evidence
that the expression of AQP4 mRNA and protein is affected by estrogen
and that ER-mediated AQP4 expression contributes to prevention
of edema formation.
During the last decade, the role of AQP4 in the ischemic brain has
been actively investigated. Since the study that showed a reduction of
hemispheric enlargement after permanent MCAO in AQP4 knockout
mice was reported [6], the notion that increased AQP4 expression
contributes to edema formation [31,32] and that suppression of AQP4
levels by therapeutics [33–36] reduces edema and infarct volume has
been supported by other studies. These studies have demonstrated
that the increase in AQP4 levels is correlated with the time of brain
edema formation after ischemic insult. However, other studies have
shown that changes in AQP4 expression are different according to
ischemic regions in MCAO models. Perivascular AQP4 expression is
decreased or nearly abolished in the ischemic core and central part of
the ischemic cortex, whereas it is partially decreased or increased in
the penumbra and border zone areas at the time of vasogenic brain
swelling [8–10,31]. In particular, abolished AQP4 expression in the
Fig. 6. Estrogen receptor-mediated AQP4 expression in the ischemic brain partly contributes to reduction of edema. (A) Representative blots and quantitative levels of AQP4 mRNA
in control and ischemic cortices of gonadally intact females and females treated with ICI182,780 (female+ICI) 24 h after MCAO (n=3 per group). Values are expressed as the
ratio versus female controls (given a nominal value of 1). #pb0.05 between female and female+ICI 24 h after MCAO (Student's t-test). (B) Representative blots and quant-
itative levels of AQP4, Kir4.1, and GFAP proteins in control and ischemic cortices of females and female+ICI 24 h after MCAO (n=3 per group). *pb0.05 compared to control of
female+ICI, #pb0.05 between females and female+ICI 24 h after MCAO (Student's t-test). (C) Infarct volumes in total hemisphere, cortex, and striatum from female (n=9)
and female+ICI (n=7) mice 3 days after MCAO. The data of the infarct volumes in females are the same as in Fig. 1 and are reproduced here for comparison. #pb0.05 compared to
the corresponding infarct volume of females (Student's t-test). (D) Brain edema in female (n=4) and female+ICI (n=4)mice 24 h after MCAO. The data of brain edema in females
are the same as in Fig. 2C and are reproduced here for comparison. *pb0.05 between female and female+ICI (Student's t-test). ICI182,789 (100 μg/mouse, s.c.) was administered
to gonadally intact females for 10 days starting 7 days before MCAO. The data are expressed as the mean±SEM.
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reperfusion [10,31]. Consistent with these studies, our results showed
that AQP4 was gradually decreased in male cortex (central part of the
ischemic cortex) and relatively well preserved in female cortex that
was rescued from ischemic insult, corresponding to the penumbra,
from 24 to 72 h after reperfusion (Fig. 3). This ﬁnding may explain
why our data are different from previous studies that reported no sex
difference in AQP4 levels [12,13]. In previous studies, there was no
statistical sex difference in water content in the ischemic brain [13],
although edema was slightly decreased in females [12]. Furthermore,
infarct volume in female brains was reduced in caudoputamen, not in
the cortex, compared to males, but AQP4 levels were examined in the
cortex [12]. The absence of statistical differences in AQP4 expression
shown in previous studies may result from using ischemic cortical
tissues where infarct volumes were similar between sexes. We chose
the time point that showed sex differences in edema formation (24 h)
and examined ipsilateral cortical tissue that was rescued from
ischemic insult in female brain. We also demonstrated that preserved
AQP4 levels in females did not result from survival of astrocytes
compared tomales, as shown by similar GFAP and Kir4.1 expression in
the sexes. Moreover, sex differences in the AQP4 levels in the ischemic
brain were supported not only by quantitativemeasurement of mRNA
and protein levels (Fig. 3), but also by immunoﬂuorescence staining
(Fig. 4). Results of the time course changes of AQP4 expression after
reperfusion showed that decreased expression was inversely corre-
lated with edema formation in male brains (Figs. 2C and 3A and B).
Considering the bidirectionality of water ﬂow through AQP4 [7,8], our
results suggest that preserved AQP4 levels in the ischemic cortex of
females contributes to water clearance during ischemia-induced
vasogenic edema.
It is well documented that estrogen provides neuroprotection
from ischemic stroke in rodent models. However, few studies have
evaluated estrogen effects on edema and AQP4 levels in the injured
brain. Single physiological or pharmacological doses of estradiol
given to OVX females were shown to be effective in reducing brain
edema following TBI, which causes BBB breakdown and vasogenic
edema [16,17]. In focal ischemic stroke models, both types of brain
edema evaluated by MRI (diffusion-weighted imaging for cytotoxic
edema, and T2-weighted imaging for vasogenic edema) were reduced
in OVX mice by estrogen replacement [14,15]. Our results are
consistent with these ﬁndings showing that estrogen replacement
reversed the increase in brain edema in OVX mice (Fig. 5D). We also
showed that AQP4 levels were preserved in estrogen-treated OVX
mice, suggesting that estrogen reduces brain edema by regulating
AQP4 expression. These ﬁndings are in contrast to previous studies
reporting that reduction in brain edema by estrogen and progesterone
was associated with a decrease in AQP4 levels in brains injured by
direct LPS injection or trauma [18,20]. The difference may be due to
different experimental models that were used. The previous studies
demonstrated induction of AQP4 levels following insults, but in our
current study, AQP4 expression was not increased but reduced in the
ischemic cortex within the time framewe examined. AQP4 expression
was correlated with edema formation rather than edema resolu-
tion. Therefore, levels of AQP4 maintained by estrogen may pro-
vide resistance to the development of brain swelling. Similar to our
ﬁndings, recent reports using transient MCAO models suggested
a positive role for AQP4 in edema reduction with neuroprotective
therapeutics. Thrombin preconditioning reduces edema and increases
AQP4 levels in the striatum at 1 h, an early time point after reper-
fusion [28]. In addition, administration of an arginine-vasopressin
antagonist during ischemic insult reduces water content and in-
creases AQP4 expression in the cortex [37]. Thus, up-regulation
of AQP4 may be involved in neuroprotection that is afforded by
some therapeutic strategies including estrogen.
Estrogen effects on AQP4 expression were further supported by
experiments with females treated with the ER antagonist, ICI182,780.This drug blocks the action of estrogen on AQP4 expression
selectively, indicating that AQP4 levels are modulated by genomic
pathways via ERs at physiological levels of estrogen. Because AQP4
mRNA levels were maintained in females until later reperfusion
periods (Fig. 3A), estrogen may maintain the transcription level of
AQP4 in the ischemic brain. However, there is currently no direct
evidence that estrogen response elements exist in the promoter of the
AQP4 gene, and that ER-binding estrogen response elements result in
induction of AQP4 transcription. In addition, the increases of infarct
volume and brain edema by ICI182,780 treatment were less than
those of OVX (Figs. 5 and 6), indicating that non-genomic effects of
estrogen such as activation of signaling pathways are involved in the
reduction of brain edema. In fact, activity of AQP4 water permeability
can be regulated by phosphorylation via activation of protein kinase A,
calcium/calmodulin-dependent protein kinase, and protein kinase C
[38], which are also affected by estrogen [39]. Therefore, further
detailed molecular work to deﬁne the mechanism by which estrogen
regulates both AQP4 levels and AQP4 activity is required. More-
over, because estrogen has various neuroprotective effects such as
antioxidant, anti-inﬂammatory and vasodilatory activities that
may prevent BBB breakdown and edema formation [11], it is pos-
sible that not only regulation of AQP4 expression but also other
protective actions may contribute to reducing ischemic brain edema
in a synergistic or additive manner. Future studies of genetic or phar-
macological suppression of AQP4 expression in the ischemic brain
during reperfusion periods will help deﬁne the estrogen effects on
brain edema.
In conclusion, sex differences in ischemic brain edema were
associated with difference in AQP4 expression, and estrogen contrib-
uted to reduction of brain edema by maintaining the levels of AQP4 in
part via ERs. These ﬁndings suggest a role for estrogen in regulating
AQP4 levels to prevent development of ischemic brain edema.
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